Details of the Optogenetic System
General Information of This Optogenetic System (OS) | ||||||
---|---|---|---|---|---|---|
OS ID |
OS00156
|
|||||
OS Name |
Optogenetic LaG9
(OptoLaG9)
|
[1] | ||||
Photoreceptor (PR) |
||||||
Cofactor | Flavin mononucleotide (FMN) | |||||
Controlled Protein | Fusion protein | A anti-EGFP nanobody | ||||
OS Application Information (1) | ||||||
---|---|---|---|---|---|---|
Mechanism of Action | J-alpha helix unfold | [ 1] | ||||
Controlled Signal Pathway | Nanobody binds to respective binder | |||||
Effect | Activation | |||||
Application | Optogentic control protein binding using light switchable nanobodies | |||||
Note | Open the door to developing light-switchable binders against a broad range of protein targets and may thus represent a first step toward an important class of photoswitchable biologics | |||||
Light Information | Activation Wavelength | 450 nm | ||||
Process | Reversible | |||||
Deactivation Wavelength | Dark | |||||
Activation Time | 2 min | |||||
Deactivation Time | Minutes | |||||
Light Intensity | 1 milliwatts per square centimeter | |||||
Expression Information | Expression Method | Transfection | ||||
Cell Lines | NIH 3T3 cells | |||||